Research

Overview

Icon offers Australia’s largest private cancer clinical trials program coordinated by a team dedicated to delivering research opportunities to as many people as possible.

We provide patients and clinicians with access to new and emerging advances in treatment, conducting trials across haematology, medical oncology and radiation oncology, participating in national and international trials across the entire Icon network.

Icon currently has 37 clinical trials open for recruitment, and has 50 active studies closed for recruitment with patients in treatment and follow-up, and over 300 patients currently on active trials across haematology, medical oncology and radiation oncology. This includes clinical trials sponsored by the pharmaceutical industry, along with collaborative studies undertaken in partnership with various universities and collaborative groups.

Search

Contact us